blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3021849

EP3021849 - NOVEL CRYSTALLINE FORMS OF PEMETREXED TROMETHAMINE SALTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.08.2020
Database last updated on 05.10.2024
FormerThe patent has been granted
Status updated on  06.09.2019
FormerGrant of patent is intended
Status updated on  01.05.2019
FormerExamination is in progress
Status updated on  06.04.2018
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Dr. Reddy's Laboratories Ltd.
8-2-337 Road No. 3
Banjara Hills
Hyderabad, Telangana 500034 / IN
[2016/21]
Inventor(s)01 / NADGOUD, Ramesh Kumar
Flat No 406
Raju Luthra Towers
Vivek Nagar
Kukatpally
Hyderabad Telangana 500072 / IN
02 / VASAM, Sridhar
Kothagudem Village
Sangem Mandal
Warangal Telangana 506330 / IN
03 / MAKIREDDY, Siva Reddy
Pakalapadu post
Sattenapalli mandal
Guntur Andhra Pradesh 522403 / IN
04 / GILLA, Goverdhan
H.No 3-63/4/205 Gayatri Residency
Gangaram
Chandanagar
Hyderabad Telangana 500050 / IN
05 / KUNHIMON, Syam Kumar Unniaran
Thanka Nivas
P.O. Nattika
Thrissur Kerala 680572 / IN
06 / SHARMA, Sachin
Village Trind
P. O. Nagrota Bagwan
Kangra Himachal Pradesh 176047 / IN
07 / DORNALA, Kumara Swamy
H No. 3-198
Village: Ghattuppal
Mandal: Chandoor
Nalgonda Telangana 508253 / IN
 [2016/21]
Representative(s)Bates, Philip Ian
Reddie & Grose LLP The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
[2019/41]
Former [2016/21]Bates, Philip Ian
Reddie & Grose LLP
16 Theobalds Road
London WC1X 8PL / GB
Application number, filing date14826506.915.07.2014
[2016/21]
WO2014IB63123
Priority number, dateIN2013CHE318016.07.2013         Original published format: IN 3180CH2013
[2017/16]
Former [2016/21]IN2013CHE318016.07.2013
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015008221
Date:22.01.2015
Language:EN
[2015/03]
Type: A1 Application with search report 
No.:EP3021849
Date:25.05.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 22.01.2015 takes the place of the publication of the European patent application.
[2016/21]
Type: B1 Patent specification 
No.:EP3021849
Date:09.10.2019
Language:EN
[2019/41]
Search report(s)International search report - published on:IN22.01.2015
(Supplementary) European search report - dispatched on:EP08.12.2016
ClassificationIPC:C07D487/04, A61K31/519, A61P35/00
[2017/02]
CPC:
C07D487/04 (EP,US); A61P35/00 (EP); C07C213/08 (US);
C07C215/10 (US); C07B2200/13 (US)
Former IPC [2016/21]A61K31/519, C07D487/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/21]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NEUARTIGE KRISTALLINE FORMEN VON PEMETREXED-TROMETHAMIN-SALZEN[2016/21]
English:NOVEL CRYSTALLINE FORMS OF PEMETREXED TROMETHAMINE SALTS[2016/21]
French:NOUVELLES FORMES CRISTALLINES DE SELS DE TROMÉTHAMINE DE PEMETREXED[2016/21]
Entry into regional phase05.02.2016National basic fee paid 
05.02.2016Search fee paid 
05.02.2016Designation fee(s) paid 
05.02.2016Examination fee paid 
Examination procedure05.02.2016Examination requested  [2016/21]
12.07.2017Amendment by applicant (claims and/or description)
10.04.2018Despatch of a communication from the examining division (Time limit: M06)
19.10.2018Reply to a communication from the examining division
23.11.2018Despatch of a communication from the examining division (Time limit: M04)
28.03.2019Reply to a communication from the examining division
02.05.2019Communication of intention to grant the patent
27.08.2019Fee for grant paid
27.08.2019Fee for publishing/printing paid
27.08.2019Receipt of the translation of the claim(s)
Opposition(s)10.07.2020No opposition filed within time limit [2020/38]
Fees paidRenewal fee
31.05.2016Renewal fee patent year 03
27.07.2017Renewal fee patent year 04
18.07.2018Renewal fee patent year 05
22.07.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.07.2014
AL09.10.2019
AT09.10.2019
CY09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
ES09.10.2019
FI09.10.2019
HR09.10.2019
IT09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
MK09.10.2019
MT09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
SM09.10.2019
TR09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
[2022/32]
Former [2022/27]HU15.07.2014
AL09.10.2019
AT09.10.2019
CY09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
ES09.10.2019
FI09.10.2019
HR09.10.2019
IT09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
MT09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
SM09.10.2019
TR09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2021/15]AL09.10.2019
AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
ES09.10.2019
FI09.10.2019
HR09.10.2019
IT09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
SM09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/51]AL09.10.2019
AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
ES09.10.2019
FI09.10.2019
HR09.10.2019
IT09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
SM09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/38]AL09.10.2019
AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
ES09.10.2019
FI09.10.2019
HR09.10.2019
IT09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SK09.10.2019
SM09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/37]AL09.10.2019
AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
ES09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
SK09.10.2019
SM09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/36]AL09.10.2019
AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
ES09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/35]AL09.10.2019
AT09.10.2019
CZ09.10.2019
ES09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
RS09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
PT10.02.2020
IS24.02.2020
Former [2020/32]AL09.10.2019
AT09.10.2019
ES09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RS09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
PT10.02.2020
IS24.02.2020
Former [2020/25]AT09.10.2019
ES09.10.2019
FI09.10.2019
HR09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RS09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
PT10.02.2020
IS24.02.2020
Former [2020/24]AT09.10.2019
ES09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
PT10.02.2020
IS24.02.2020
Former [2020/23]AT09.10.2019
ES09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
GR10.01.2020
PT10.02.2020
Former [2020/22]FI09.10.2019
LT09.10.2019
NL09.10.2019
SE09.10.2019
BG09.01.2020
NO09.01.2020
PT10.02.2020
Former [2020/21]NL09.10.2019
NO09.01.2020
Former [2020/20]NL09.10.2019
Documents cited:Search[XP]WO2013179248  (FRESENIUS KABI ONCOLOGY LTD [IN]) [XP] 14 * Claims 1, 7, 16, 18, 23, 26; examples 06-09, 11, 12. *;
 [E]WO2014198337  (SYNTHON BV [NL]) [E] 14* Claims; example 2. *;
 [XP]  - Anonymous, "PEMETREXED TROMETHAMINE SALTS AND ITS SOLID STATE FORMS THEREOF. IP.com Number: IPCOM000236645D.", (20140507), pages 1 - 26, An IP.com Prior Art Database Technical Disclosure., URL: http://priorart.ip.com/IPCOM/000236645, (20161117), XP055320637 [XP] 1-15 * the whole document *
International search[Y]EP0432677  (UNIV PRINCETON [US]);
 [A]CN1552713  (HENGRUI MEDICINE CO LTD JIANGS [CN]);
 [A]WO2006136837  (ASTEX THERAPEUTICS LTD [GB], et al);
 [A]WO2010030598  (REDDYS LAB LTD DR [IN], et al);
 [Y]WO2011064256  (AZAD PHARMACEUTICAL INGREDIENTS AG [CH], et al);
 [A]US2011319354  (LAYTON MARK E [US], et al);
 [A]WO2012015810  (EAGLE PHARMACEUTICALS INC [US], et al)
by applicantEP0432677
 US5344932
 WO0114379
 CN1552713
 CN1778802
 US7138521
 CN101033227
 WO2008021405
 WO2010031357
 CN101691371
 WO2011064256
    - CHARLES et al., Organic Process Research & Development, (19990000), vol. 3, pages 184 - 188
    - EDWARD et al., J. Med. Chem., (19920000), vol. 35, pages 4450 - 4454
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.